ProShares UltraShort NASDAQ Biotechnology
5 hedge funds and large institutions have $691K invested in ProShares UltraShort NASDAQ Biotechnology in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
OMC
1
Old Mission Capital
Chicago,
Illinois
|
$266K |
2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$397K |
3 |
3
Morgan Stanley
New York
|
$8K |
Top Sellers
1 |
1
IMC Chicago
Chicago,
Illinois
|
$0 |
2 |
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$0 |
3 |
3
UBS Group
Zurich,
Switzerland
|
$18K |